OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation

• Yan Cui ,

  Contributed equally to this work with: Yan Cui, Ying Ying

  Affiliation Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong, China

  ⨯
• Ying Ying ,

  Contributed equally to this work with: Yan Cui, Ying Ying

  Affiliation Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong, China

  ⨯
• Andrew van Hasselt,

  Affiliation Department of Surgery, Chinese University of Hong Kong, Hong Kong, China

  ⨯
• Ka Man Ng,

  Affiliation Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong, China

  ⨯
• Jun Yu,

  Affiliation Institute of Digestive Disease, Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, China

  ⨯
• Qian Zhang,

  Affiliation Department of Urology, Peking University 1st Hospital & Institute of Urology, Peking University Health Science Center, Beijing, China

  ⨯
• Jie Jin,

  Affiliation Department of Urology, Peking University 1st Hospital & Institute of Urology, Peking University Health Science Center, Beijing, China

  ⨯
• Dingxie Liu,

  Affiliation Johns Hopkins Singapore, Singapore, Singapore

  ⨯
• Johng S. Rhim,

  Affiliation Center for Prostate Disease Research, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States of America

  ⨯
• Sun Young Rha,

  Affiliation Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea

  ⨯
• Myriam Loyo,

  Affiliation Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Anthony T. C. Chan,

  Affiliation Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong, China

  ⨯
• Gopesh Srivastava,

  Affiliation Department of Pathology, University of Hong Kong, Hong Kong, China

  ⨯
• George S. W. Tsao,

  Affiliation Department of Anatomy, University of Hong Kong, Hong Kong, China

  ⨯
• Grant C. Sellar,

  Current address: Wyeth Research, Translational Medicine Research Collaboration, Dundee, United Kingdom

  Affiliation Cancer Research UK Edinburgh Oncology Unit, University of Edinburgh Cancer Research Center, Edinburgh, United Kingdom

  ⨯
• Joseph J. Y. Sung,

  Affiliation Institute of Digestive Disease, Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong, China

  ⨯
• David Sidransky,

  Affiliation Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America

  ⨯
•  [ ... ],
• Qian Tao

  * E-mail: qtao@clo.cuhk.edu.hk

  Affiliations Cancer Epigenetics Laboratory, State Key Laboratory in Oncology in South China, Sir YK Pao Center for Cancer, Department of Clinical Oncology, Hong Kong Cancer Institute and Li Ka Shing Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong, China, Johns Hopkins Singapore, Singapore, Singapore

  ⨯
• [ view all ]
• [ view less ]